Jenburkt Pharmaceuticals Ltd — Dividend/Bonus, 20-06-2025: Corp. Action

Jenburkt Pharmaceuticals Limited has announced a board meeting to discuss the financial results for the quarter and half-year. The company has fixed the record date for dividend payment and shareholder eligibility for remote e-voting in connection with its 40th Annual General Meeting. This update ensures shareholders know the key dates for dividend entitlement and voting rights, reflecting active corporate governance and shareholder engagement.